Detalhe da pesquisa
1.
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
Lancet
; 395(10232): 1259-1267, 2020 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32171422
2.
Pharmacokinetics, Safety, and Efficacy of an Allometric Miltefosine Regimen for the Treatment of Visceral Leishmaniasis in Eastern African Children: An Open-label, Phase II Clinical Trial.
Clin Infect Dis
; 68(9): 1530-1538, 2019 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30188978